This study was designed to observe the possible protective effects of a triple‐fermented barley ( Hordeum vulgare L.) extract ( FB e) obtained by saccharification and using Saccharomyces cerevisiae and Weissella cibaria in alleviating gastric damage induced by a hydrochloric acid ( HC l) and ethanol (Et OH ) mixture in mice. After oral administration of FB e (300, 200, and 100 mg/kg) followed by 1 hr before and after the single treatment of HC l/Et OH (H/E) mixture, the hemorrhagic lesion scores, histopathology of the stomach, gastric nitrate/nitrite content, lipid peroxidation, and antioxidant defense systems including catalase and superoxide dismutase activities were observed. Following a single oral treatment of H/E‐induced gastric damages as measured by hemorrhagic gross lesions and histopathological gastric, ulcerative lesions were significantly and dose‐dependently ( p < 0.01 or p < 0.05) inhibited in mice, when all three different doses of FB e were administered as compared to those in H/E control mice. In particular, FB e also increased gastric nitrate/nitrite content and strengthened the antioxidant defense, with a decrease in the level of gastric lipid peroxidation, but increased the activities of CAT and SOD . Moreover, the effects of FB e are comparable to that of ranitidine, a reference drug. The obtained results suggest that this fermented barley extract prevented mice from H/E‐induced gastric mucosal damages through the suppression of inflammatory responses and oxidative stress‐responsive free radicals. Thus, FB e can be useful to treat patients suffering from gastric mucosal disorders as a potent food supplement, and thereby, it would increase the necessity of application in the food industry.
No takes yet. Share an insight, caveat, or question.
Lim et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: